Muscle biopsy findings in DM2 have been reported to be similar to those in DM1. The authors used myosin heavy chain immunohistochemistry and enzyme histochemistry for fiber type differentiation on muscle biopsies. Their results show that DM2 patients display a subpopulation of type 2 nuclear clump and other very small fibers and, hence, preferential type 2 fiber atrophy in contrast to type 1 fiber atrophy in DM1 patients.
Patients and methods. Deltoid, biceps brachii, and vastus lateralis muscle biopsies from nine patients from three European countries were re-examined. All had PROMM phenotype and expanded DM2 alleles in the range of 5 to 25 kb as assessed by Southern analysis. The biopsies were previously taken for diagnostic purposes and used for this study after informed consent from the patients. The Table provides a description of clinical features of the DM2 patients in this study. Electromyography (EMG) showed myotonia for all patients.
Muscle biopsies. Deltoid muscle biopsies were obtained from three French DM2 patients, two of whom originated from France and one from Serbia. Detailed clinical features of one patient (F3) from the series have been previously reported. 9 Vastus lateralis muscle biopsies from three patients from two unrelated Finnish DM2 families not previously reported were examined (FIN1 and FIN3 are cousins). Biceps brachii muscle biopsies were obtained from three patients from unrelated Italian DM2 families. Control subjects were age-matched and mutation-verified DM1 patients from different families (deltoid, three; vastus, three; biceps, two), with similar muscle weakness shown on muscle biopsy, and one recessive congenital myotonia patient with homozygous R894X mutation in the CLCN1 gene.
Histologic procedure. Serial transverse muscle cryostat sections 6 m and 10 m thick were cut for immunohistochemical (IHC) and routine histochemical stainings, respectively, with hematoxylin and eosin (H-E), Gomori's trichrome, and nicotinamide adenine dinucleotide (NADH) tetrazolium reductase. 10 A standard myofibrillar ATPase staining protocol was used after preincubation at pH 4.3, pH 4.6, and pH 9.4 or 10.4. 10 Ventana Nexes automated immunostainer (Ventana Medical Systems, Tucson, AZ) was used for IHC, with avidin-biotin-complex method followed by diaminobenzidine (DAB) detection. Monoclonal primary antibodies against different myosin heavy chain (MHC) isotypes were used at the following dilutions: MHCfast, 1:400 (My-32, Sigma Chemical Co., St. Louis, MO); MHCslow, 1:5,000 (NOQ7.5.4D, Sigma); and MHCd (developmental), 1:10 (RNMy2/9D2, Novocastra Laboratories, Newcastle upon Tyne, UK). Quantitative evaluation of fiber diameter was made with Scion Image (Scion Corporation, Frederick, MD) on images taken with a microscope (3.2 ϫ 10 original magnification) and sections stained with slow and fast MHC IHC. The size of muscle fibers was assessed by measuring the "smallest fiber diameter." The number of muscle fibers evaluated in each sample ranged from 537 to 5,151 (see supplementary content on the Neurology Web site). All data were elaborated using Microcal Origin (Microcal Software Inc., Northampton, MA). The metahistograms were normalized to normal mean diameter for men and women. Atrophy and hypertrophy factors were also calculated. 10
Results. Common histopathologic findings. Routine histochemical stainings of DM2 muscle sections showed myopathic changes, including increased fiber size variation and internalized nuclei (figure 1). Increases of connective tissue, fat replacement, or necrotic fibers were rarely observed. Structural changes mainly consisted of occasional moth-eaten fibers, whereas subsarcolemmal masses and ring fibers were particularly rare. Occasional rimmed vacuolar fibers or ragged-red fibers (RRF) were encountered in some specimens. Central nuclei were frequent in DM1 and DM2 biopsies, and many small fibers with nuclear clumps were observed in most DM2 specimens (see figure 1 ). Rounded or thin angular atrophic fibers were usually scattered, whereas fiber type grouping or targetoid fibers were not encountered. Fiber type analysis. The metahistograms based on IHC data in figure 2 show preferential fiber type 2 atrophy in vastus lateralis, biceps, and deltoid muscles from DM2 patients. Hypertrophy of type 2 fibers in biceps of DM2 patients is also evident. In DM1 patients, marked atrophy of type 1 fibers and slight atrophy of type 2 fibers are present in all muscles. A control sample from the recessive congenital myotonia patient revealed no preferential type 2 atrophy (data not shown). A subpopulation of small fibers (diameter Յ 20 m), including all the nuclear clump fibers (which expressed almost exclusively fast MHC [type 2 fiber] isoform), was seen in the DM2 biopsies. Nuclear clumps and other small type 2 fibers were prominent in some vastus lateralis and deltoid samples even at onset of symptoms. IHC and the ATPase method gave identical fiber type distribution patterns for fibers more than 40 m in diameter, but many fibers less than 20 m in diameter, well identified by MHC IHC, were not readily discernible with H-E and ATPase (see figure 1) . A small proportion of fibers of all sizes expressed fast and slow MHC isoforms, and few regenerating fibers expressing the developmental myosin isotype were observed. The presence of 2B fibers was confirmed in all DM2 biopsies in this study, although not in constant proportions (see table E-1 on the Neurology Web site for a summary of the key figures of the histographic analysis). The calculated atrophy and hypertro-phy factors are in full agreement with the results derived from other methods in this study.
Discussion.
Our study shows preferential type 2 fiber atrophy in DM2 and absence of type 1 fiber atrophy in contrast to DM1. IHC determination of fiber type distribution revealed many small fibers (diameter Յ 20 m), including the nuclear clump fibers, practically all of which were identified as type 2 fibers. This study showed a variable fiber type distribution in DM2 depending on muscle site. In particular, the previously described type 1 fiber predominance was only attested in deltoid biopsies and was not confirmed in vastus lateralis and biceps brachii muscles. Hypertrophy was variable in both fiber types, which may be the result of secondary compensation or myotonia.
Further studies will be required to determine the fiber type of nuclear clump fibers appearing in more Figure 2 . Metahistograms showing the preferential atrophy of type 2 fibers in vastus lateralis, biceps, and deltoid muscles from DM2 patients, and marked type 1 fiber atrophy and slight type 2 atrophy in DM1 patients. The results are based on IHC stained sections. Atrophy (A) and hypertrophy (H) factors for type 1 and type 2 fibers: vastus lateralis; DM2 vs DM1: A1, 70.91 vs 227.01; A2, 739.64 vs 247.36; H1, 473.56 vs 100.31; H2, 100.33 vs 270.45; biceps; DM2 vs DM1: A1, 18.90 vs 538.17; A2, 252.11 vs 190.48; H1, 135.43 vs 0.00; H2, 680.28 vs 11.58; deltoid; DM2 vs DM1: A1, 152.64 vs 325.76; A2, 1, 232.96 vs 180.94; H1, 179.36 vs 47.18; H2, 287.23 vs 54.55 . Upper limits for the value of atrophy and hypertrophy factors in vastus lateralis: (men) A1, 150; A2, 150; H1, 150; H2, 400; (women) A1, 100; A2, 200; H1, 400; H2, 150; and biceps (men) A1, 150; A2, 150; H1, 300; H2, 500; (women) A1, 100; A2, 150; H1, 200; H2, 150. 10 
